AlzeCure Pharma Publishes Updated Company Presentation Following the Eli Lilly and QuantumCell Agreements

STOCKHOLM, SE / ACCESS Newswire / September 18, 2026 / AlzeCure Pharma AB ("AlzeCure" or "The Company") (STO:ALZCUR)(FRA:AC6), which develops small-molecule drug candidates for CNS diseases with a focus on Alzheimer's disease and pain, today …